Precision BioSciences (FRA:PBS0) Change In Receivables : €8.05 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Precision BioSciences Change In Receivables?

Precision BioSciences's change in receivables for the quarter that ended in Dec. 2024 was €-0.14 Mil. It means Precision BioSciences's Accounts Receivable increased by €0.14 Mil from Sep. 2024 to Dec. 2024 .

Precision BioSciences's change in receivables for the fiscal year that ended in Dec. 2024 was €8.55 Mil. It means Precision BioSciences's Accounts Receivable declined by €8.55 Mil from Dec. 2023 to Dec. 2024 .

Precision BioSciences's Accounts Receivable for the quarter that ended in Dec. 2024 was €0.22 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Precision BioSciences's Days Sales Outstanding for the three months ended in Dec. 2024 was 32.81.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Precision BioSciences's liquidation value for the three months ended in Dec. 2024 was €6.20 Mil.

Precision BioSciences Change In Receivables Historical Data

The historical data trend for Precision BioSciences's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precision BioSciences Change In Receivables Chart

Precision BioSciences Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-7.43

8.42

-0.22

-0.17

8.55

Precision BioSciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Receivables	Get a 7-Day Free Trial															2.38	-0.78	0.17	8.80	-0.14

Precision BioSciences Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €8.05 Mil.

Precision BioSciences (FRA:PBS0) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Precision BioSciences's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.219	/	0.609	*	91
=	32.81

2. In Ben Graham's calculation of liquidation value, Precision BioSciences's accounts receivable are only considered to be worth 75% of book value:

Precision BioSciences's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	82.428	-	76.395	+	0.75 * 0.219	+	0.5 * 0
=	6.20

Precision BioSciences Change In Receivables Related Terms

Thank you for viewing the detailed overview of Precision BioSciences's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Precision BioSciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Precision BioSciences Inc (FRA:PBS0) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

DTIL:USA

Address

302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701

Website

https://www.precisionbiosciences.com

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Precision BioSciences Headlines

No Headlines